Related Experiment Video

Updated: Aug 16, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Viruses with deletions in antiapoptotic genes as potential oncolytic agents

Ta-Chiang Liu1, David Kirn

  • 1Molecular Neurosurgery Laboratory, Massachusetts General Hospital and Harvard Medical School, MA, USA. tachiangliu@yahoo.com

Oncogene
|September 13, 2005
PubMed

Insights

Replication-selective oncolytic viruses offer a promising cancer treatment. By leveraging cancer cells' apoptosis resistance, modified viruses can enhance efficacy for broader therapeutic applications.

Area of Science:

  • Oncology
  • Virology
  • Biotechnology

Background:

  • Oncolytic viruses are a novel cancer therapy, but require enhanced selectivity and potency.
  • Cancer cells often possess apoptosis-resistant pathways.
  • Viruses naturally express antiapoptotic genes to counteract host defenses.

Purpose of the Study:

  • To review the development of oncolytic viruses engineered to exploit cancer cell apoptosis resistance.
  • To discuss strategies for improving virotherapy targeting a wide range of cancers.
  • To identify potential obstacles and future optimization directions.

Main Methods:

  • Review of current research on replication-selective oncolytic viruses.
  • Analysis of viral antiapoptotic gene functions and their interaction with cancer cell pathways.
  • Examination of strategies for complementing viral deletions with cancer-specific genetic alterations.

Main Results:

  • Oncolytic viruses with deletions in antiapoptotic genes can be complemented by cancer cells' inherent resistance to apoptosis.
  • This complementary mechanism can lead to enhanced viral replication and cancer cell lysis (oncolysis).
  • Targeting apoptosis pathways offers a route to broaden the applicability of virotherapy.

Conclusions:

  • Exploiting the interplay between viral and cancer cell apoptosis pathways is a key strategy for improving oncolytic virotherapy.
  • Further research is needed to overcome potential obstacles and optimize this therapeutic approach.
  • This strategy holds promise for developing more effective and broadly applicable cancer treatments.

More Related Videos

Ex Vivo Infection of Live Tissue with Oncolytic Viruses12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...